Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravitreal sustained-release ganciclovir.

T J Smith1, P A Pearson, D L Blandford

  • 1Department of Ophthalmology, University of Kentucky, Lexington.

Archives of Ophthalmology (Chicago, Ill. : 1960)
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRICHINELLA INFECTIONS IN WILDLIFE FROM PENNSYLVANIA: VARIATION IN EXPOSURE AMONG COYOTE (CANIS LATRANS), GRAY FOX (UROCYON CINEREOARGENTEUS), AND RED FOX (VULPES VULPES).

The Journal of parasitology·2024
Same author

TRICHINELLA MURRELLI POZIO AND LA ROSA, 2000 IN A GRAY FOX (UROCYON CINEREOARGENTEUS) FROM PENNSYLVANIA: A NEW HOST RECORD FOR THIS ZOONOTIC NEMATODE.

The Journal of parasitology·2024
Same author

Touching reality: Bridging the user-researcher divide in upper-limb prosthetics.

Science robotics·2023
Same author

On the Element That Kills in Chloroform, and Other Allied Chemicals.

Chicago medical examiner·2023
Same author

The presence, morphology and clinical significance of vertebral body malformations in an Australian population of French Bulldogs and Pugs.

Australian veterinary journal·2021
Same author

A cryogenic continuously rotating half-wave plate mechanism for the POLARBEAR-2b cosmic microwave background receiver.

The Review of scientific instruments·2020
Same journal

The economics of the initial preventive physical examination in medicare-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

December 2011 archives web quiz winner.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

About this journal.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

In memoriam: goodwin m. Breinin, MD (1918-2011).

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
See all related articles

New devices deliver ganciclovir directly to the eye, offering a potential treatment for cytomegalovirus retinitis in AIDS patients with fewer side effects than current intravenous therapies.

Area of Science:

  • Ophthalmology
  • Drug Delivery Systems
  • Virology

Background:

  • Cytomegalovirus retinitis is a serious complication in patients with acquired immunodeficiency syndrome (AIDS).
  • Current intravenous ganciclovir treatments for cytomegalovirus retinitis often cause severe side effects.
  • There is a need for improved drug delivery methods for ocular infections in immunocompromised patients.

Purpose of the Study:

  • To develop and evaluate novel drug delivery devices for sustained release of ganciclovir in the eye.
  • To assess the efficacy and safety of these devices in a preclinical rabbit eye model.

Main Methods:

  • Development of polymer-based devices designed to release ganciclovir at controlled rates (2 µg/h and 5 µg/h in vitro).
  • In vivo implantation of these devices into the vitreous humor of rabbit eyes.

Related Experiment Videos

  • Monitoring of intravitreal ganciclovir concentrations and assessment of device tolerability and toxicity over time.

    • Main Results:

    • Sustained intravitreal ganciclovir levels were achieved: 9 mg/L for over 80 days and 16 mg/L for over 42 days.
    • The implanted devices were well tolerated in rabbit eyes.
    • No toxic effects were observed that could be attributed to the polymers used in the device construction.

    Conclusions:

    • The developed ganciclovir-releasing devices can maintain therapeutic drug levels for extended durations in the eye.
    • These devices demonstrate good tolerability in a preclinical model, suggesting potential for reduced systemic side effects.
    • This novel drug delivery approach may offer a promising alternative for managing cytomegalovirus retinitis in AIDS patients.